BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 21514265)

  • 41. Detection of survivin-expressing circulating cancer cells (CCCs) in peripheral blood of patients with gastric and colorectal cancer reveals high risks of relapse.
    Yie SM; Lou B; Ye SR; Cao M; He X; Li P; Hu K; Rao L; Wu SM; Xiao HB; Gao E
    Ann Surg Oncol; 2008 Nov; 15(11):3073-82. PubMed ID: 18670822
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Combination of cytology, fluorescence in situ hybridization for aneuploidy, and reverse-transcriptase polymerase chain reaction for human mammaglobin/mammaglobin B expression improves diagnosis of malignant effusions.
    Fiegl M; Haun M; Massoner A; Krugmann J; Müller-Holzner E; Hack R; Hilbe W; Marth C; Duba HC; Gastl G; Grünewald K
    J Clin Oncol; 2004 Feb; 22(3):474-83. PubMed ID: 14752070
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Outcome-based profiling of astrocytic tumours identifies prognostic gene expression signatures which link molecular and morphology-based pathology.
    Beetz C; Bergner S; Brodoehl S; Brodhun M; Ewald C; Kalff R; Krüger J; Patt S; Kiehntopf M; Deufel T
    Int J Oncol; 2006 Nov; 29(5):1183-91. PubMed ID: 17016650
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Circulating microRNA for the identification of forensically relevant body fluids.
    Hanson EK; Ballantyne J
    Methods Mol Biol; 2013; 1024():221-34. PubMed ID: 23719955
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The origin, function, and diagnostic potential of extracellular microRNAs in human body fluids.
    Liang H; Gong F; Zhang S; Zhang CY; Zen K; Chen X
    Wiley Interdiscip Rev RNA; 2014; 5(2):285-300. PubMed ID: 24259376
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Nucleic acid-based biomarkers in body fluids of patients with urologic malignancies.
    Ralla B; Stephan C; Meller S; Dietrich D; Kristiansen G; Jung K
    Crit Rev Clin Lab Sci; 2014 Aug; 51(4):200-31. PubMed ID: 24878357
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The circulating transcriptome as a source of non-invasive cancer biomarkers: concepts and controversies of non-coding and coding RNA in body fluids.
    Fernandez-Mercado M; Manterola L; Larrea E; Goicoechea I; Arestin M; Armesto M; Otaegui D; Lawrie CH
    J Cell Mol Med; 2015 Oct; 19(10):2307-23. PubMed ID: 26119132
    [TBL] [Abstract][Full Text] [Related]  

  • 48. New method uses biomarkers to discriminate cancer cells present in bodily fluids.
    Lake F
    Expert Rev Proteomics; 2011 Dec; 8(6):687. PubMed ID: 22195314
    [No Abstract]   [Full Text] [Related]  

  • 49. [Advance in human free circulating DNA].
    Hu Y; Ni H
    Yi Chuan; 2008 Jul; 30(7):815-20. PubMed ID: 18779122
    [TBL] [Abstract][Full Text] [Related]  

  • 50. NIH to fund studies into extracellular RNA-based biomarkers.
    Coaker H
    Bioanalysis; 2012 Sep; 4(18):2204. PubMed ID: 23227473
    [No Abstract]   [Full Text] [Related]  

  • 51. Plasma RNA integrity analysis: methodology and validation.
    Wong BC; Lo YM
    Ann N Y Acad Sci; 2006 Sep; 1075():174-8. PubMed ID: 17108208
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Mass spectrometric based analysis, characterization and applications of circulating cell free DNA isolated from human body fluids.
    Sharma VK; Vouros P; Glick J
    Int J Mass Spectrom; 2011 Jul; 304(2-3):172-183. PubMed ID: 21765648
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Use of free circulating DNA for diagnosis, prognosis and treatment of cancer.
    Sirera R; Camps C
    Expert Opin Med Diagn; 2007 Sep; 1(1):143-6. PubMed ID: 23489277
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Extracellular RNAs: development as biomarkers of human disease.
    Quinn JF; Patel T; Wong D; Das S; Freedman JE; Laurent LC; Carter BS; Hochberg F; Van Keuren-Jensen K; Huentelman M; Spetzler R; Kalani MY; Arango J; Adelson PD; Weiner HL; Gandhi R; Goilav B; Putterman C; Saugstad JA
    J Extracell Vesicles; 2015; 4():27495. PubMed ID: 26320940
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Unified algorithm of study of free and initiated biological fluid crystallogenesis].
    Martusevich AK; Kamakin NF
    Klin Lab Diagn; 2007 Jun; (6):21-4. PubMed ID: 17682475
    [No Abstract]   [Full Text] [Related]  

  • 56. The extracellular fluid response to surgical treatment.
    KOVACH JC; HEINZEN BR; PIFER M
    J Int Coll Surg; 1955 Feb; 23(2 Pt 1):209-20. PubMed ID: 14354252
    [No Abstract]   [Full Text] [Related]  

  • 57. Biogenesis, delivery, and function of extracellular RNA.
    Patton JG; Franklin JL; Weaver AM; Vickers K; Zhang B; Coffey RJ; Ansel KM; Blelloch R; Goga A; Huang B; L'Etoille N; Raffai RL; Lai CP; Krichevsky AM; Mateescu B; Greiner VJ; Hunter C; Voinnet O; McManus MT
    J Extracell Vesicles; 2015; 4():27494. PubMed ID: 26320939
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The origin, function and diagnostic potential of extracellular microRNA in human body fluids.
    Turchinovich A; Cho WC
    Front Genet; 2014; 5():30. PubMed ID: 24575125
    [No Abstract]   [Full Text] [Related]  

  • 59. Cancer cells move and spread faster in thicker extracellular fluids.
    Nature; 2022 Nov; ():. PubMed ID: 36323893
    [No Abstract]   [Full Text] [Related]  

  • 60. On an Equal Distribution of Excitement, and of the Circulating Fluids.
    Kinglake
    Lond Med Phys J; 1822 Dec; 48(286):488-494. PubMed ID: 30494661
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.